Discover more insights into Soluble Programmed 가용성 프로그램

Keywords frequently search together with Soluble Programmed 가용성 프로그램

Narrow sentence examples with built-in keyword filters

Soluble Programmed sentence examples within death ligand 1



Serum levels of inhibitory costimulatory molecules and correlations with levels of innate immune cytokines in patients with pulmonary tuberculosis


Soluble Programmed Death-Ligand 1 (sPD-L1) as a Novel Biomarker for the Combination of Anti-PD-L1 Antibody and Radiotherapy for Glioma Patients.

Soluble Programmed sentence examples within cell death 1



Soluble Programmed Cell Death-1 Predicts Hepatocellular Carcinoma Development During Nucleoside Analogue Treatment


A prospective, open-label, interventional study protocol to evaluate treatment efficacy of nivolumab based on serum-soluble PD-L1 concentration for patients with metastatic and unresectable renal cell carcinoma

Soluble Programmed sentence examples within cell death protein



Serum soluble PD‐1 plays a role in predicting infection complications in patients with acute pancreatitis


Nanobubbles Containing sPD-1 and Ce6 Mediate Combination Immunotherapy and Suppress Hepatocellular Carcinoma in Mice


Learn more from Soluble Programmed 가용성 프로그램


Soluble Programmed sentence examples within cell death ligand



The clinical implication of soluble PD-L1 (sPD-L1) in patients with breast cancer and its biological function in regulating the function of T lymphocyte


[The expression and clinical significance of serum soluble programmed cell death ligand-1 in adult patients with community-acquired pneumonia].

Soluble Programmed sentence examples within death protein 1



The role of soluble programmed death protein-1 (sPD-1) and soluble programmed death ligand-1 (sPD-L1) in rat corneal transplantation rejection.


Diagnostic Usefulness of Cytokine and Chemokine Levels in the Cerebrospinal Fluid of Patients with Suspected Tuberculous Meningitis.

Soluble Programmed sentence examples within death 1 ligand



Soluble PD-L1 is a predictive and prognostic biomarker in advanced cancer patients who receive immune checkpoint blockade treatment

Soluble Programmed sentence examples within Serum Soluble Programmed



Soluble Programmed Death Molecule 1 (sPD-1) As Predictor of Interstitial Lung Disease in Rheumatoid Arthritis


Molecular Mechanism of Expression Changes of Immunological Indexes of PD-1/sPD-L1 after Radiotherapy in Nonsmall Cell Lung Cancer

Soluble Programmed sentence examples within Circulating Soluble Programmed



Soluble PD-L1 is a predictive and prognostic biomarker in advanced cancer patients who receive immune checkpoint blockade treatment


Analysis of circulating soluble programmed death 1 (PD-1), neuropilin 1 (NRP-1) and human leukocyte antigen-G (HLA-G) in psoriatic patients

Soluble Programmed sentence examples within soluble programmed death



Serum levels of inhibitory costimulatory molecules and correlations with levels of innate immune cytokines in patients with pulmonary tuberculosis


Soluble Programmed Death-Ligand 1 (sPD-L1) as a Novel Biomarker for the Combination of Anti-PD-L1 Antibody and Radiotherapy for Glioma Patients.

Soluble Programmed sentence examples within soluble programmed cell



The relationship between the expression of soluble programmed cell death-1 and cancer pain


Serum soluble PD‐1 plays a role in predicting infection complications in patients with acute pancreatitis


The relationship between the expression of soluble programmed cell death-1 and cancer pain



Serum levels of inhibitory costimulatory molecules and correlations with levels of innate immune cytokines in patients with pulmonary tuberculosis



Soluble Programmed Death-Ligand 1 (sPD-L1) as a Novel Biomarker for the Combination of Anti-PD-L1 Antibody and Radiotherapy for Glioma Patients.



Soluble Programmed Death Molecule 1 (sPD-1) As Predictor of Interstitial Lung Disease in Rheumatoid Arthritis



Molecular Mechanism of Expression Changes of Immunological Indexes of PD-1/sPD-L1 after Radiotherapy in Nonsmall Cell Lung Cancer



Unbalanced expression of membrane-bound and soluble programmed cell death 1 and programmed cell death ligand 1 in systemic juvenile idiopathic arthritis.



Soluble type immune checkpoint regulators using multiplex luminex immunoassay in chronic hepatitis B patients



Serum levels of soluble programmed death-ligand 1 (sPD-L1): A possible biomarker in predicting post-treatment outcomes in patients with early hepatocellular carcinoma.



Serum soluble PD‐1 plays a role in predicting infection complications in patients with acute pancreatitis



Soluble programmed death-1 is predictive of hepatitis B surface antigen loss in chronic hepatitis B patients after antiviral treatment



Biomarker Evidence of the Persistent Inflammation, Immunosuppression and Catabolism Syndrome (PICS) in Chronic Critical Illness (CCI) After Surgical Sepsis.



Nanobubbles Containing sPD-1 and Ce6 Mediate Combination Immunotherapy and Suppress Hepatocellular Carcinoma in Mice



The clinical implication of soluble PD-L1 (sPD-L1) in patients with breast cancer and its biological function in regulating the function of T lymphocyte



[The expression and clinical significance of serum soluble programmed cell death ligand-1 in adult patients with community-acquired pneumonia].



Soluble Programmed Cell Death-1 Predicts Hepatocellular Carcinoma Development During Nucleoside Analogue Treatment



The role of soluble programmed death protein-1 (sPD-1) and soluble programmed death ligand-1 (sPD-L1) in rat corneal transplantation rejection.



Soluble PD-L1 is a predictive and prognostic biomarker in advanced cancer patients who receive immune checkpoint blockade treatment



A prospective, open-label, interventional study protocol to evaluate treatment efficacy of nivolumab based on serum-soluble PD-L1 concentration for patients with metastatic and unresectable renal cell carcinoma



Elevated levels of soluble PD-L1 are associated with reduced recurrence in papillary thyroid cancer



Analysis of Plasma EBV-DNA and Soluble Checkpoint Proteins in Nasopharyngeal Carcinoma Patients after Definitive Intensity-Modulated Radiotherapy



The prognostic role of soluble transforming growth factor-β related with soluble programmed death-ligand 1 in biliary tract cancer.



Diagnostic value of soluble programmed cell death protein-1 in type-1 autoimmune hepatitis in Egyptian children



Diagnostic Usefulness of Cytokine and Chemokine Levels in the Cerebrospinal Fluid of Patients with Suspected Tuberculous Meningitis.



High blood levels of soluble OX40 (CD134), an immune costimulatory molecule, indicate reduced survival in patients with advanced colorectal cancer.



Plasma soluble programmed death ligand 1 levels predict clinical response in peripheral T‐cell lymphomas


More Soluble Programmed 가용성 프로그램 sentence examples
10.3760/CMA.J.ISSN.0254-5101.2019.12.005

Changes and significance of serum soluble programmed death-1 in patients with chronic hepatitis C


More Soluble Programmed 가용성 프로그램 sentence examples
10.1158/2326-6074.CRICIMTEATIAACR18-B121

Abstract B121: Checkpoint inhibitor vaccine stimulates antitumor T-cells that block tumor growth



Discrepant range of sPD‐1 in different studies of chronic hepatitis B. A letter in response to Soluble programmed death‐1 is a useful indicator for inflammatory and fibrosis severity in chronic hepatitis B



Soluble programmed death-ligand 1 indicate poor prognosis in hepatocellular carcinoma patients undergoing transcatheter arterial chemoembolization



Dynamics of Soluble Programmed Death-Ligand 1 (sPDL1) during Chemotherapy and Its Prognostic Implications in Cancer Patients: Biomarker Development in Immuno-oncology



Serum sPD-1 and sPD-L1 as Biomarkers for Evaluating the Efficacy of Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer Patients.



Analysis of circulating soluble programmed death 1 (PD-1), neuropilin 1 (NRP-1) and human leukocyte antigen-G (HLA-G) in psoriatic patients



Association Between Activation of the Programmed Cell Death-1 (PD-1)/Programmed Death-Ligand 1 (PD-L1) Pathway and Pain in Patients with Cancer



Soluble programmed death-ligand 1 are highly expressed in peripheral T-cell lymphoma: a biomarker for prognosis


More Soluble Programmed 가용성 프로그램 sentence examples
10.3760/CMA.J.ISSN.1001-7097.2019.03.002

Clinical significance of sPD-1 and sPD-L1 in serum and urine of children with primary nephrotic syndrome



Preliminary observations on soluble programmed cell death protein-1 as a prognostic and predictive biomarker in patients with metastatic melanoma treated with patient-specific autologous vaccines



Soluble sPD-L1 and Serum Amyloid A1 as Potential Biomarkers for Lung Cancer


Learn more from Soluble Programmed 가용성 프로그램

Soluble Programmed 가용성 프로그램


Soluble Programmed 가용성 프로그램
Encyclopedia 백과사전